Prevention of CVD in patients with CKD |
| |
Authors: | Nishimoto-Hazuku Ai Node Koichi |
| |
Institution: | Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine. |
| |
Abstract: | Chronic kidney disease (CKD) is characterized by proteinuria and kidney dysfunction caused by multiple factors. Metabolic disorders such as diabetes, dyslipidemia and hypertension are involved in the underlying pathological mechanisms of CKD and cardiovascular disease (CVD). In patients with CKD, CVD is a major cause of morbidity and mortality. Recent clinical studies have revealed that intervention by angiotensin II blockade with ARB and ACEI reduces CKD and CVD. Accordingly, earlier intervention to metabolic disorders with blockers for angiotensin II and aldosterone may prevent CKD as well as CVD associated with CKD. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|